Biofrontera Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was USD 0.036 million compared to USD 0.031 million a year ago. Revenue was USD 14.58 million compared to USD 14.21 million a year ago. Net loss was USD 17.32 million compared to net income of USD 4.71 million a year ago. Basic loss per share from continuing operations was USD 12.73 compared to basic earnings per share from continuing operations of USD 5.24 a year ago. Diluted loss per share from continuing operations was USD 12.73 compared to diluted earnings per share from continuing operations of USD 5.22 a year ago.